近日，我国高性能硅光电倍增器（SiPM）国产化取得重大突破。记者从中广核核技术发展有限公司 （以下简称"中广核技"）获悉，由其旗下中广核京师光电科技（天津）有限公司（简称"中京光电"）打 造的SiPM封装产线成功通线，并提前达成器件良率超90%的目标，标志着国内高性能SiPM产品实现关 键自主化，成功打破国外长期垄断局面。 SiPM作为核心光电转换器件，因其高灵敏度、低噪声、低功耗等显著优势，在核医疗影像、核测控装 备、高能物理研究、生物科学等前沿领域应用广泛，潜力巨大。 此前，国内SiPM市场长期被国外企业主导，实现相关核心元器件自主可控已被明确列入国家《核技术 应用产业高质量发展三年行动方案（2024-2026）》。 为攻克这一技术，中广核技携手北京师范大学共同设立中京光电，以完全拥有自主知识产权的外延电阻 淬灭（EQR）SiPM、位置灵敏SiPM等核心技术为抓手，积极推动科技成果转化。此次产线成功通线及 高良率目标的达成，有效填补了国内高性能SiPM产品的空白，为产业链安全稳定提供保障。 中京光电总经理王晓峰表示，"半导体光敏传感器量产对环境和工艺要求极为严苛，为此，公司斥资建 设了最高达百级的高标准洁 ...

6月27日，用友网络科技股份有限公司（下称"用友网络"或"用友"，SH:600588）递交招股书，报考在港 交所上市。据贝多财经了解，用友网络是一家A股上市公司，于2001年5月在上海证券交易所上市。 撰稿|张君 来源|贝多财经 又一家A股上市公司实施"A+H"上市方案。 彼时，用友网络的公司名称为北京用友软件股份有限公司，证券简称为"用友软件"，IPO发行价为36.68 元/股，后于2016年1月更名为"用友网络"。而截至2025年6月27日，用友网络的股价报收13.10元/股，市 值约为447.63亿元。 而就在2022年1月，用友网络披露定增结果，公司本次以31.95元/股的价格发行1.66亿股股份，发行对象 合计17位，募资总额为52.98亿元，参与定增的对象包括高瓴旗下HHLR、GIC、摩根大通等。 天眼查App信息显示，用友网络成立于1995年1月，位于北京市海淀区。目前，该公司的注册资本约为 34.17亿元，法定代表人为王文京，主要股东包括北京用友科技有限公司、上海用友科技咨询有限公司 等。 | | | RATE HASTA 都在用的商业量调工具 | 457 M ARRE | | | | --- ...

在当天的发布会上，博众精工董事长吕绍林特别感慨。他说，面对无人无资金无核心技术，更缺乏 大客户指引等重重困境，他们凭着一份坚韧和信念，极其不易地走到了今天。"在电子显微镜这条科技 攻关的'长征路'上，我们仅仅迈出了第一步。前方，必然还有无数场硬仗等着我们去打。" 当天发布的国产首台200kV场发射商用透射电子显微镜，不仅彻底打破我国高端透射电子显微镜长 期受制于人的被动局面，更铸就了中国高端科学仪器自主化进程中的崭新里程碑。博众仪器依托完全自 主可控的电子光学核心技术、高稳定性超低纹波电源，以及安全可靠的供应链体系，成功贯通了从核心 技术突破到高端装备产业化的全链条。 透射电子显微镜（TEM），是洞察纳米至原子尺度微观世界的"科学慧眼"，是半导体、前沿材料、 生命科学、原子级制造等战略领域的核心装备，其自主可控直接关乎国家战略科技力量与产业链安全。 然而，透射电子显微镜市场长期被国际巨头垄断，尤其在200kV场发射这一高端机型领域，国产化率几 近为零。博众仪器是由博众精工孵化的国家高新技术企业，自2020年3月成立以来，锚定高端透射电镜 及电子束共性技术的自主研发，通过核心技术自主攻坚，系统性地破解核心技术困 ...

Group 1 - The core viewpoint is that Beijing Geling Deep Vision Technology Co., Ltd. experienced a significant decline in revenue for 2024, primarily due to a substantial drop in sales from Agricultural Bank [2][3] - The company reported a total revenue of 117 million yuan for 2024, representing a year-on-year decrease of 55.30% [2][3] - Sales from Agricultural Bank decreased by 75.96%, accounting for 44.44% of the annual sales total [3] Group 2 - In the fourth quarter of 2024, the company achieved a revenue of 56.58 million yuan, which constituted 48.26% of the total annual revenue and marked an increase of 33.89 percentage points year-on-year [2][3] - The acquisition of Guokeyi Dao contributed an additional revenue of 15.26 million yuan from smart terminal products [2][3] - The company's accounts receivable at the end of the year amounted to 143 million yuan, reflecting a year-on-year increase of 24.68%, mainly due to the consolidation of Guokeyi Dao [2]

Core Viewpoint - The company, Changchuan Technology, is experiencing explosive growth in its performance, with a projected profit of 360 million to 420 million yuan for the first half of the year, representing a year-on-year increase of 67.54% to 95.46% [1] Group 1: Financial Performance - In 2024, the company reported a revenue of 3.642 billion yuan, a year-on-year increase of 105.15% [5] - The net profit attributable to shareholders reached 458 million yuan, showing a staggering year-on-year growth of 915.14% [5] - In the first quarter of this year, net profit surged by 2623.82% to 111 million yuan, attributed to strong market demand and effective cost control [6] Group 2: Industry Position and Challenges - Changchuan Technology is a leading enterprise in China's integrated circuit testing equipment sector, focusing on the R&D, production, and sales of specialized equipment [4] - The company aims to promote technological upgrades and import substitution in the domestic semiconductor equipment industry [4] - Despite strong performance, the company faces challenges such as project delays, regulatory warnings, and a low domestic semiconductor equipment localization rate of only 13.6% [2][7] Group 3: R&D Investment and Future Plans - The company plans to invest 3.84 billion yuan in a semiconductor equipment R&D project focusing on the iteration of testing machines and AOI equipment, with a long implementation period of five years [7] - R&D investment has significantly increased from 25 million yuan in 2016 to 967 million yuan in 2024, with R&D accounting for 28.14% of revenue [10] - The company has over 1,000 authorized patents, including more than 350 invention patents, and its products are integrated into the supply chains of major domestic and international companies [10] Group 4: Previous Project Delays and Regulatory Issues - The company has faced delays in previous fundraising projects, particularly a 260 million yuan project for probe station R&D, which has been postponed twice [9][11] - The Zhejiang Securities Regulatory Bureau issued a warning letter to the company for issues related to premature revenue recognition, improper management of raised funds, and inadequate sales internal controls [11]

Core Viewpoint - Hangzhou Changchuan Technology Co., Ltd. has announced its largest refinancing plan since its listing, aiming to raise no more than 3.132 billion yuan, with significant investments directed towards semiconductor equipment R&D and working capital [1][10]. Group 1: Financial Performance - The company expects a profit of 360 million to 420 million yuan for the first half of the year, representing a year-on-year growth of 67.54% to 95.46% [2]. - In 2024, the company reported a revenue of 3.642 billion yuan, a year-on-year increase of 105.15%, and a net profit of 458 million yuan, up 915.14% [7]. - In Q1 of this year, net profit surged by 2623.82% to 111 million yuan, attributed to strong market demand and effective cost control [9]. Group 2: R&D and Market Position - Changchuan Technology is a leading player in China's integrated circuit testing equipment sector, focusing on the R&D, production, and sales of specialized equipment [6]. - The company has significantly increased its R&D investment from 25 million yuan in 2016 to 967 million yuan in 2024, a nearly 40-fold increase, with R&D accounting for 28.14% of revenue in 2024 [13]. - The company holds over 1,000 authorized patents, including more than 350 invention patents, and its products are integrated into the supply chains of major domestic and international companies [13]. Group 3: Challenges and Regulatory Issues - Despite impressive financial results, the company faces challenges, including delays in previous fundraising projects and a low domestic semiconductor equipment localization rate of 13.6% [3][10]. - The company has encountered regulatory warnings due to issues such as premature revenue recognition and mismanagement of raised funds, leading to warnings issued to top executives [14].

作为国内 RV 减速器市场份额排名第二的龙头企业 ， 浙江环动机器人关节科技股份有限公司 ( 以下简称 " 环动科技 ") 的科创板 IPO 进程一直备受关注。 此前，上海证券交易所公开了环动科技关于科创板 IPO 第 二轮问询的回复内容 ， 不少媒体认为这距离 环动科技 正式上市不远。 招股书显示，环动科技的产品 非常聚焦，主要就是 RV 减速器、精密配件及谐波减速器，其中 2022-2024 年，其主要产品 RV 减速器销售收入占主营业务收入比例分别为 95.06% 、 95.05% 和 94.58% ， 而 RV 减速器主要应用于中大负载多关节机器人 ， 而这部分市场原先一直是国外巨头的自留地。 近年来不少企业， 逐步突破设计理论、精密磨齿工艺、高精度装配等关键技术 ，填补 了 国内高端 减速机 空白。 通过这些国产核心零部件，最为典型的就是国产机器人开始在全球舞台亮相，例如近期埃夫特的中大 负载机器人就正式亮相德国 Automatica 展会与 ABB 、 FUNNC 等企业的产品同台竞技。 环动科技 的 前身为双环传动机械研究院 ， 自 2013 年组建团队以来， 就 始终聚焦工业机器人 " 心脏 ...

"企业存在的意义，就两个字'有用'。"奥来德董事长轩景泉的话语直白有力——做解决行业痛点的产 品，做推动产业升级的技术。站在成立20周年的新起点，奥来德如何持续深耕"材料+设备"双赛道，再 启新程？近日，上海证券报记者实地探访其生产基地，探寻这家硬科技企业的突围密码。 从"追光者"到"造光者" 走进奥来德有机材料合成车间，记者看到工作人员和生产设备均处于高速运转状态。工作人员正熟练地 操作系统，设置反应温度、压力、搅拌转速等参数，并将灰白色的原材料粉末填入反应釜中。 "这看似普通的粉体，相当于整个OLED屏幕发光的'灯芯'，是最关键的材料。"奥来德生产部经理李明 介绍，这些按克计算的有机发光材料，在OLED产业链中专利壁垒很高，决定着屏幕的色彩饱和度、亮 度和寿命。 回溯2005年创业初期，OLED行业基本被少数海外企业垄断。在一次偶然的机会中，轩景泉接触到吉林 大学超分子实验室的OLED材料项目，他敏锐地意识到，这是一条前景广阔的全新赛道，于是义无反顾 地投身于OLED领域。 从手机屏幕到车载中控，从折叠平板到VR眼镜，显示屏已成为人们感知世界的"窗口"。随着技术进 步，OLED屏幕凭借轻薄、低功耗、高显示 ...

国泰海通证券股份有限公司 关于北京格灵深瞳信息技术股份有限公司 上海证券交易所： 根据贵所于近日出具的《关于北京格灵深瞳信息技术股份有限公司 2024 年 年度报告的信息披露监管问询函》（上证科创公函【2025】0188 号），以下简称 "问询函"）的要求，国泰海通证券股份有限公司（以下简称"持续督导机构"）会 同公司及相关中介机构，就问询函提及的事项逐项进行了认真讨论、核查与落实， 并出具了明确的核查意见如下： （本核查意见中若合计数与各分项数值相加之和在尾数上存在差异为四舍 五入所致。鉴于部分信息涉及商业秘密，因此针对该部分内容进行豁免披露。） 问题 1. 关于经营业绩及重要客户。年报显示，公司 2024 年实现营业收入 万元，占比 48.26%，同比增加 33.89 个百分点，收入季节性特征与前期差异较 大。公司向第一大客户中国农业银行股份有限公司（下称"农行"）销售额为 个百分点，且公司与农行的框架协议即将于 2025 年 9 月到期，后续能否续签存 在一定的不确定性。近三年公司向除农行外客户销售额分别为 8,702.71 万元、 请公司：（1）分季度列示农行以及其他客户 2024 年度和 2025 ...

Core Viewpoint - The credit rating of Aerospace Hongtu Information Technology Co., Ltd. is maintained at BBB+ with a negative outlook due to concerns over its military procurement qualifications and financial performance [4][6][8]. Company Overview - Aerospace Hongtu is a leading company in the domestic remote sensing application software sector, possessing core technologies and a complete industrial chain [4][12]. - The company has faced challenges, including a suspension of military procurement qualifications since 2024, which has negatively impacted new orders and revenue [8][17]. Financial Performance - In 2024, the company reported total revenue of 15.75 billion yuan, a decline of 13.39% year-on-year, primarily due to the suspension of military procurement qualifications and increased project budget constraints from local governments [22][28]. - The company's net profit for 2024 was significantly negative, with a loss of 13.94 billion yuan, reflecting a substantial erosion of profitability [9][22]. - The total assets of the company increased from 59.91 billion yuan in 2022 to 64.77 billion yuan in 2023, but the owner's equity decreased from 27.10 billion yuan to 23.07 billion yuan during the same period [9][24]. Debt and Liquidity - The company has a high leverage level, with a debt-to-equity ratio reaching historical highs due to continuous losses and a significant increase in liabilities [9][24]. - As of March 2025, the company had a total debt of 28.79 billion yuan, with a substantial portion being short-term debt [9][26]. - The company faces considerable short-term liquidity pressure, relying heavily on external financing for debt repayment [25][30]. Market Position and Industry Trends - The remote sensing satellite industry in China is expected to grow, with the market size projected to exceed 260 billion yuan in 2024 [11][12]. - The company is positioned well within the industry, but competition is increasing, particularly in the remote sensing data processing and application sectors [10][12]. - The company has been actively expanding its satellite data sources and enhancing its service offerings, but the suspension of military procurement has hindered its growth potential [12][18]. Research and Development - The company maintains a high level of R&D investment, with 2024 R&D expenditures amounting to 3.16 billion yuan, representing 21.03% of total revenue [15][24]. - Despite the high R&D investment, the company faces challenges in converting R&D efforts into profitable outcomes, particularly in light of its recent financial struggles [14][15]. Future Outlook - The company is expected to continue facing revenue declines in 2025 due to ongoing issues with military procurement qualifications, although the loss magnitude may narrow [28][30]. - The company plans to reduce capital expenditures in 2025, focusing on improving cash flow and operational efficiency [28][30].